120 related articles for article (PubMed ID: 18397320)
1. Investigation of the interaction between the atypical agonist c[YpwFG] and MOR.
Gentilucci L; Squassabia F; De Marco R; Artali R; Cardillo G; Tolomelli A; Spampinato S; Bedini A
FEBS J; 2008 May; 275(9):2315-37. PubMed ID: 18397320
[TBL] [Abstract][Full Text] [Related]
2. Topological exploration of cyclic endomorphin-1 analogues, structurally defined models for investigating the bioactive conformation of MOR agonists.
Gentilucci L; Tolomelli A; Squassabia F
Protein Pept Lett; 2007; 14(1):51-6. PubMed ID: 17266651
[TBL] [Abstract][Full Text] [Related]
3. Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model.
Bedini A; Baiula M; Gentilucci L; Tolomelli A; De Marco R; Spampinato S
Peptides; 2010 Nov; 31(11):2135-40. PubMed ID: 20713109
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of the affinity toward mu-opioid receptors of atypical, lipophilic ligands based on the sequence c[-Tyr-Pro-Trp-Phe-Gly-].
Cardillo G; Gentilucci L; Tolomelli A; Spinosa R; Calienni M; Qasem AR; Spampinato S
J Med Chem; 2004 Oct; 47(21):5198-203. PubMed ID: 15456262
[TBL] [Abstract][Full Text] [Related]
5. Redoubling the ring size of an endomorphin-2 analog transforms a centrally acting mu-opioid receptor agonist into a pure peripheral analgesic.
Piekielna J; De Marco R; Gentilucci L; Cerlesi MC; Calo' G; Tömböly C; Artali R; Janecka A
Biopolymers; 2016 May; 106(3):309-17. PubMed ID: 27038094
[TBL] [Abstract][Full Text] [Related]
6. Cyclic mu-opioid receptor ligands containing multiple N-methylated amino acid residues.
Adamska-Bartłomiejczyk A; Janecka A; Szabó MR; Cerlesi MC; Calo G; Kluczyk A; Tömböly C; Borics A
Bioorg Med Chem Lett; 2017 Apr; 27(8):1644-1648. PubMed ID: 28318942
[TBL] [Abstract][Full Text] [Related]
7. The inverse type II β-turn on D-Trp-Phe, a pharmacophoric motif for MOR agonists.
Gentilucci L; Tolomelli A; De Marco R; Spampinato S; Bedini A; Artali R
ChemMedChem; 2011 Sep; 6(9):1640-53. PubMed ID: 21721130
[TBL] [Abstract][Full Text] [Related]
8. Potent μ-Opioid Receptor Agonists from Cyclic Peptides Tyr-c[D-Lys-Xxx-Tyr-Gly]: Synthesis, Biological, and Structural Evaluation.
Li Y; Cazares M; Wu J; Houghten RA; Toll L; Dooley C
J Med Chem; 2016 Feb; 59(3):1239-45. PubMed ID: 26789491
[TBL] [Abstract][Full Text] [Related]
9. Potent opioid peptide agonists containing 4'-[N-((4'-phenyl)-phenethyl)carboxamido]phenylalanine (Bcp) in place of Tyr.
Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Schiller PW
Chem Biol Drug Des; 2008 Nov; 72(5):337-40. PubMed ID: 19012569
[TBL] [Abstract][Full Text] [Related]
10. The mu- and delta-opioid pharmacophore conformations of cyclic beta-casomorphin analogues indicate docking of the Phe3 residue to different domains of the opioid receptors.
Brandt W; Stoldt M; Schinke H
J Comput Aided Mol Des; 1996 Jun; 10(3):201-12. PubMed ID: 8808737
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration.
Perlikowska R; Piekielna J; Gentilucci L; De Marco R; Cerlesi MC; Calo G; Artali R; Tömböly C; Kluczyk A; Janecka A
Eur J Med Chem; 2016 Feb; 109():276-86. PubMed ID: 26785295
[TBL] [Abstract][Full Text] [Related]
12. Complex of an active mu-opioid receptor with a cyclic peptide agonist modeled from experimental constraints.
Fowler CB; Pogozheva ID; Lomize AL; LeVine H; Mosberg HI
Biochemistry; 2004 Dec; 43(50):15796-810. PubMed ID: 15595835
[TBL] [Abstract][Full Text] [Related]
13. Translation of structure-activity relationships from cyclic mixed efficacy opioid peptides to linear analogues.
Anand JP; Porter-Barrus VR; Waldschmidt HV; Yeomans L; Pogozheva ID; Traynor JR; Mosberg HI
Biopolymers; 2014 Jan; 102(1):107-14. PubMed ID: 24436042
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity profile of new analogues of the cyclic opioid peptide H-Tyr-c[D-Cys-Gly-Phe(pNO2)-D-Cys]-NH2 containing (S)-alpha-hydroxymethylcysteine in place of cysteine.
Witkowska R; Chung NN; Schiller PW; Zabrocki J
J Pept Sci; 2005 Jun; 11(6):361-3. PubMed ID: 15635653
[TBL] [Abstract][Full Text] [Related]
15. Preferred conformation of endomorphin-1 in aqueous and membrane-mimetic environments.
Fiori S; Renner C; Cramer J; Pegoraro S; Moroder L
J Mol Biol; 1999 Aug; 291(1):163-75. PubMed ID: 10438613
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of cyclic endomorphin-2 analogs.
Perlikowska R; do-Rego JC; Cravezic A; Fichna J; Wyrebska A; Toth G; Janecka A
Peptides; 2010 Feb; 31(2):339-45. PubMed ID: 19995587
[TBL] [Abstract][Full Text] [Related]
17. A Blocking Group Scan Using a Spherical Organometallic Complex Identifies an Unprecedented Binding Mode with Potent Activity In Vitro and In Vivo for the Opioid Peptide Dermorphin.
Strack M; Bedini A; Yip KT; Lombardi S; Siegmund D; Stoll R; Spampinato SM; Metzler-Nolte N
Chemistry; 2016 Oct; 22(41):14605-10. PubMed ID: 27553294
[TBL] [Abstract][Full Text] [Related]
18. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
Schmidt R; Wilkes BC; Chung NN; Lemieux C; Schiller PW
Int J Pept Protein Res; 1996 Nov; 48(5):411-9. PubMed ID: 8956074
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of opioid ligand-receptor interaction models: the structural basis of mu vs delta selectivity.
Mosberg HI; Fowler CB
J Pept Res; 2002 Dec; 60(6):329-35. PubMed ID: 12464111
[TBL] [Abstract][Full Text] [Related]
20. A Cyclic Tetrapeptide ("Cyclodal") and Its Mirror-Image Isomer Are Both High-Affinity μ Opioid Receptor Antagonists.
Weltrowska G; Nguyen TM; Chung NN; Wood J; Ma X; Guo J; Wilkes BC; Ge Y; Laferrière A; Coderre TJ; Schiller PW
J Med Chem; 2016 Oct; 59(19):9243-9254. PubMed ID: 27676089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
